Document is current
Any future updates will be listed below
-
Authors
Hall, Daniel L. https://orcid.org/0000-0002-4069-5324
Levine, Beverly J.
Jeter, Elizabeth
Chandler, Allison
Tooze, Janet A.
Duffecy, Jenna
Victorson, David
Gradishar, William
Leach, Joseph
Saphner, Thomas
Smith, Mary Lou
Penedo, Frank
Mohr, David C.
Cella, David
Wagner, Lynne I.
-
Funding
Funding for this research was provided by:
National Cancer Institute (CA173193, 1UG1CA189828)
National Center for Complementary and Integrative Health (K23AT010157)
- License Information
-
More Information
Article History
Received: 26 January 2022
Accepted: 11 July 2022
First Online: 5 August 2022
Declarations
:
: David C. Mohr, Ph.D. has accepted honoraria and consulting fees from Apple, Inc., Otsuka Pharmaceuticals, Pear Therapeutics, and the One Mind Foundation, and has an ownership interest in Adaptive Health, Inc. Frank Penedo, Ph.D. is a paid consultant for Blue Note Therapeutics. All other authors have confirmed no conflicts of interest.
: Informed consent was obtained from all individual participants included in the study.
: All human study activities have been approved by the appropriate ethics committee and were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Patients signed informed consent regarding publishing their data.
